Retatrutide 20mg

Retatrutide 20mg — Research Overview

Retatrutide 20mg is a next-generation multi-agonist peptide investigated in metabolic research for its activity at GLP-1, GIP, and glucagon receptors. In laboratory settings, this unique receptor profile makes it a valuable tool for studying complex energy-regulation pathways, insulin sensitivity and lipid metabolism. This compound is supplied by ReGen-X exclusively for scientific and laboratory research.

Mechanism of Action (Research Context)
In controlled research environments, retatrutide has been shown to interact with three key metabolic signalling pathways:

• GLP-1 receptor activity — associated with appetite signalling and glucose regulation
• GIP receptor activity — involved in insulin and fat metabolism
• Glucagon receptor activity — linked to energy expenditure and lipid mobilisation

This triple-pathway engagement makes retatrutide of particular interest for metabolic and endocrine research models studying obesity, insulin resistance and energy homeostasis.

Research Summary
Retatrutide has been evaluated in pre-clinical and clinical research models for its potential role in:

• Metabolic rate modulation
• Glucose and insulin signalling pathways
• Fat oxidation and lipid transport
• Appetite and energy balance

Browse our full range of Metabolic & GLP-1 research compounds.

Product Specifications

• Compound: Retatrutide 20mg
• Quantity: 20mg
• Form: Lyophilised research peptide
• Included: 3ml bacteriostatic water (for laboratory reconstitution only)
• Storage: Refrigerated per laboratory standards

Important Research Use Notice
This product is sold strictly for laboratory and scientific research use only. It is not a medicine, not a supplement, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied.